中文名 | CZC-54252 hydrochloride |
英文名 | N-(2-((5-chloro-2-((2-methoxy-4-morpholinophenyl)amino)pyrimidin-4-yl)amino)phenyl)methanesulfonamide hydrochloride |
英文别名 | CZC-54252 HCl N-(2-((5-chloro-2-((2-methoxy-4-morpholinophenyl)amino)pyrimidin-4-yl)amino)phenyl)methanesulfonamide hydrochloride |
CAS | 1784253-05-9 |
化学式 | C22H26Cl2N6O4S |
分子量 | 541.45 |
溶解度 | 溶于DMSO (高达50 mg/ml)。 |
存储条件 | -20° |
稳定性 | 从提供的购买之日起稳定2年。在DMSO中的溶液可以在-20 ° 储存长达3个月。 |
外观 | 固体 |
颜色 | Off-white |
产品用途 | CZC-54252 is a potent inhibitor of leucine-rich repeat kinase 2 (LRRK2) with IC50 values 1.28 nM and 1.85 nM for wild-type and G2019S mutant forms of LRRK2 respectively. CZC-54252 attenuates neuronal injury induced by LRRK2-G2019S mutant activity in primary human neurons (EC50 = 1 nM). Activating mutations in leucine-rich repeat kinase 2 (LRRK2) are present in a subset of Parkinson's disease (PD) patients and may represent an attractive therapeutic target. |
靶点 | IC50: 1.28 nM (Wild-type LRRK2) and 1.85 nM (G2019S LRRK2) |
参考资料 展开查看 | 1. Nigel Ramsden, et al. Chemoproteomics-based design of potent LRRK2-selective lead compounds that attenuate Parkinson's disease-related toxicity in human neurons. ACS Chem Biol. 2011 Oct 21;6(10):1021-8. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 1.847 ml | 9.234 ml | 18.469 ml |
5 mM | 0.369 ml | 1.847 ml | 3.694 ml |
10 mM | 0.185 ml | 0.923 ml | 1.847 ml |
5 mM | 0.037 ml | 0.185 ml | 0.369 ml |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!